Effects of Music on the Psyche of Neuroendocrine Tumour Patients Undergoing Peptide Receptor Radionuclide Therapy

  • Remigius Orjiukwu
  • Margot Staudinger
  • Daniel Putzer
  • Dietmar Waitz
  • Michael Gabriel
  • Irene J. Virgolini
Part of the Medical Radiology book series (MEDRAD)


Radionuclide peptide receptor-based therapy (PRRT) is an established therapeutic option in inoperable metastatic neuroendocrine tumours (NETs), who show somatostatin receptor (SSTR) expression in SSTR scintigraphy. According to the Innsbruck protocol for performing PRRT our department for PRRT only few side effects are observed. PRRT is generally very well tolerated, and the results favour the combined use of radiolabeled SST analogues providing a customised therapy strategy for tumour control in advanced stages. Overall response rates (minor response, partial remission, stable disease) to PRRT are more than 75 %, and even in patients with progressive disease palliation of tumour-related symptoms may be observed. In patients with advanced disease stages, older age, poor Karnovsky performance index and diminished organ function due to pre-treatment with chemotherapy, radioactivity doses should be adapted to the individual situation. An improvement of quality of life parameters is documented in many of the NET patients reported by the EORTC questionnaire which covers the global well-being of the patient. PRRT is well established in the treatment of NET patients suffering progressive, metastatic disease. These patients are often confronted with the diagnosis of a growing tumor and only few well established treatment options. However, the treatment with high dose radioactivity is not commonly known and may cause a certain anxiety level. A correlation between music and human biology has been described and “music therapy” has been applied in different medical treatments. In a randomised controlled study, we examined the influence of systematic application of music via MP3 players on the psyche of NET patients undergoing PRRT. In both groups of patients receiving music or not, a statistically significant difference could be measured for the global severity index (i.e. a measure for the self-reported clinically relevant psychological symptoms) between the day of admittance and the day of remission from our therapy unit, but the effect was more pronounced in the music group. Furthermore, during application of PRRT a significant reduction of the acute anxiety level was observed in both groups, and this effect was more pronounced in the patient group receiving music, and was statistically significant after application of radioactivity between the music group and the control group. We conclude that selected music positively influences patient care by reducing the acute anxiety level during application of PRRT as well as by reducing clinically relevant psychological symptoms.


Religious Experience Music Therapy Peptide Receptor Radionuclide Therapy Global Severity Index Amino Acid Solution 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Abrams B, Decker GM (2001) Music, Cancer and Immunity. Clin J Oncol Nurs 5(5):222–224PubMedGoogle Scholar
  2. Barnason S, Zimmerman L, Nieveen J (1995) The effects of music interventions on anxiety in the patient after coronary artery bypass grafting. Heart Lung 24:124–132PubMedCrossRefGoogle Scholar
  3. Blood AJ, Zatorre RJ (2001) Intensely pleasurable responses to music correlate with activity in brain regions implicated with reward and emotion. Proc Natl Acad Sci 98:11818–11823PubMedCentralPubMedCrossRefGoogle Scholar
  4. Bodei L, Cremonesi M, Zoboli S, Grana C, Bartolomei M, Rocca P, Caracciolo (2003) Receptor-mediated radionuclide therapy with 90Y-DOTA-TOC in association with amino acid infusion: a phase I study. Eur J Nucl Med Mol Imag 30:207–216CrossRefGoogle Scholar
  5. Bottomly A (1998) Anxiety and the adult cancer patient. Eur J Cancer Care 7:217–222CrossRefGoogle Scholar
  6. Brown CJ, Chen CAN, Dworkin SF (1989) Music in the control of human pain. Music Ther 8(1):47–60CrossRefGoogle Scholar
  7. Carlson KLM, Broome M, Vessey JA (2000) Using distraction to reduce reported pain, fear, and behavioral distress in children and adolescents: a multisite study. JSPN 5(2):75–85PubMedGoogle Scholar
  8. Derogatis LR, Morrow GR, Fettin J et al (1983) The prevalence of psychiatric disorders among cancer patients. J Am Med Assoc 249:751–757CrossRefGoogle Scholar
  9. Duffaud F, Therasse P (2000) New guidelines to evaluate the response to treatment in solid tumors. Bull Cancer 87(12):881–886Google Scholar
  10. Franke GH (2000) Manual zum BSI–Brief Symptom Inventory. In: vonDerogatis LR (Kurzform der SCL-90-R), Beltz Test, GöttingenGoogle Scholar
  11. Forrer F, Uusijärvi H, Storch D, Maecke HR, Mueller-Brand J (2005) Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTA-TOC. J Nucl Med 46:1310–1316PubMedGoogle Scholar
  12. Gabriel M, Decristoforo C, Kendler C, Dobrozemsky G, Heute D, Uprimny C et al (2007) 68Gallium-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Nucl Med 48:508–518PubMedCrossRefGoogle Scholar
  13. Gabriel M, Oberauer A, Dobrozemsky G, Decristoforo C, Putzer D, Kendler D et al (2009) 68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy. J Nucl Med 50:1427–1434PubMedCrossRefGoogle Scholar
  14. Gabriel M, Andergassen U, Putzer D, Kroiss A, Waitz D, von Guggenberg E, Kendler D, Virgolini IJ (2010) Individualized peptide-related-radionuclide-therapy concept using different radiolabeled somatostatin analogs in advanced cancer patients. Q J Nucl Med Mol Imaging (in press)Google Scholar
  15. Hoffman BM, Zevon MA, D`Arrigo MC, Cecchini TB (2004) Screening for distress in cancer patients: the NCCN rapid-screening measure. Psycho-Oncol 13:792–799. http://nuklearmedizin.i-med.ac.at/ http://www.youtube.com/watch?v=D15LOMR-aJY http://psychology.wikia.com/wiki/Healing
  16. Kemper K, Danhauer SC (2005) Music as therapy. South Med J 98:282–288PubMedCrossRefGoogle Scholar
  17. Kwekkeboom L (2003) Music versus distraction for procedural pain and anxiety in patients with cancer. Oncol Nurs Forum 30:433–440PubMedCrossRefGoogle Scholar
  18. Kwekkeboom DJ, de Herder WW, Kam BL, van Eijck CH, van Essen M, Kooij PP et al (2008) Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3]octreotate: toxicity, efficacy, and survival. J Clin Oncol 26:2124–2130PubMedCrossRefGoogle Scholar
  19. Laux L, Glanzmann P, Schaffner P, Spielberger CD (1981) Das state-trait-angstinventar. Beltz, WeinheimGoogle Scholar
  20. Lazaroff I, Shimshoni R (2000) Effects of medical resonance therapy music on patients with psoriasis and neurodermitis. Integr Psychol Behav Sci 35(3):189–198CrossRefGoogle Scholar
  21. Lee OKA, Chung YFL, Chan MF, Chan WM (2005) Music and its effect on the physiological responses and anxiety levels of patients receiving mechanical ventilation: a pilot study. J Clin Nurs 14:609–620PubMedCrossRefGoogle Scholar
  22. McCaffrey R, Freeman E (2003) Effect of music on chronic osteoarthritis in older people. J Adv Nurs 44(5):517–524PubMedCrossRefGoogle Scholar
  23. McCaul K, Malott J (1984) Distraction and coping with pain. Psychol Bull 95(3):516–533PubMedCrossRefGoogle Scholar
  24. Nilsson U, Unosson M, Rawal N (2005) Stress reduction in patients exposed to calming music postoperatively: a randomized controlled trial. Eur J Anaesthesiol 22:96–102PubMedCrossRefGoogle Scholar
  25. Öberg K, Jelic S (2008) ESMO guidelines working group neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19(2):ii104–105PubMedGoogle Scholar
  26. Pape W (2005) Brain and Music–Comments on music-related brain research. Music Ther Today 6(2):185–214Google Scholar
  27. Putzer D, Gabriel M, Henninger B, Kendler D, Uprimny C, Dobrozemsky C, Decristororo C, Bale R, Jaschke W, Virgolini I (2009) Bone metastases in neuroendocrine tumor patients: 68Ga-DOTA-Tyr3-octreotide positron emission tomography in comparison to computed tomography and bone scintigraphy. J Nucl Med 50:1214–1221PubMedCrossRefGoogle Scholar
  28. Rodrigues M, Traub-Weidinger T, Li S, Ibi B, Virgolini I (2006) Comparison of 111In-DOTAD-Phe1-Tyr3-octreotide and 111In-DOTA-lanreotide scintigraphy and dosimetry in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 33:532–540PubMedCrossRefGoogle Scholar
  29. Rodi B (1998) Musiktherapie in der Onkologie. In: Muthny FA (ed) Psychoonkologie–bedarf, maßnahmen und wirkungen am beispiel des Herforder modells. Pabst, LengerichGoogle Scholar
  30. Sabo CE, Michael SR (1996) The influence of personal message with music on anxiety and side effects associated with chemotherapy. Cancer Nurs 19:283–289PubMedCrossRefGoogle Scholar
  31. Siedliecki SL, Good M (2006) Effect of music on power, pain, depression and disability. J Adv Nurs 54(5):553–562PubMedCrossRefGoogle Scholar
  32. Smith M, Casey L, Johnson D, Gwede C, Riggin OZ (2001) Music as a therapeutic intervention for anxiety in patients receiving radiation therapy. Oncol Nurs Forum 28:855–862PubMedGoogle Scholar
  33. Spintge R, Droh R (1992) Music medicine. MMB Music, St. Louis, MOGoogle Scholar
  34. Spielberger CD (1972) Anxiety as an emotional state. In: Spielberger CD (ed) Anxiety: current trends in theory and research. Academic Press, New YorkGoogle Scholar
  35. Spielberger CD, Lushene RE, McAdoo WG (1977) Theory and measurement of anxiety states. In: Cattell RB, Dreger RM (eds) Handbook of modern personality theory. Hemisphere/Wiley, New YorkGoogle Scholar
  36. Staudinger M (2008) Psychologische effekte durch ablenkung mittels musik im rahmen der nuklearmedizinischen onkologie. (Diploma Thesis) Leopold-Franzens-Universität InnsbruckGoogle Scholar
  37. Teunissen JJ, Kwekkeboom DJ, Krenning EP (2004) Quality of life in patients with gastroenteropancreatic tumors treated with analog [177Lu-DOTA0, Tyr3]octreotate. J Clin Oncol 22:2724–2729PubMedCrossRefGoogle Scholar
  38. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, national cancer institute of the United States, national cancer Institute of Canada. J Natl Cancer Inst 92:205–216PubMedCrossRefGoogle Scholar
  39. Traub-Weidinger T, von Guggenberg E, Dobrozemsky G, Kendler D, Eisterer W, Bale R, Putzer D, Gabriel M, Virgolini I (2010) Preliminary experience with 68Ga-DOTA-Lanreotide positron emission tomography. Q J Nucl Med Mol Imaging (in press)Google Scholar
  40. Turk DC (1996) Psychological aspects of chronic pain and disability. J Muscoskel Pain 4:145–153Google Scholar
  41. Van Essen M, Krenning EP, Kam BL, de Jong M, Valkema R, Kwekkeboom DJ (2009) Peptide-receptor radionuclide therapy for endocrine tumors. Nat Rev Endocrinol 5:382–392PubMedGoogle Scholar
  42. Vessey JA, Carlson KL, McGill J (1994) Use of distraction with children during an acute pain experience. Nurs Res 43:369–372PubMedGoogle Scholar
  43. Villemure C, Bushnell MC (2002) Cognitive modulation of pain: how do attention and emotion influence pain processing? Pain 95:195–199PubMedCrossRefGoogle Scholar
  44. Virgolini I, Britton K, Buscombe J, Moncayo R, Paganelli G, Riva P (2002) 111Indium and 90Y-DOTA-Lanreotide: results and implications of the MAURITIUS trial. Semin Nucl Med 32:148–155PubMedCrossRefGoogle Scholar
  45. Virgolini I, Gabriel M, von Guggenberg E, Putzer D, Kendler D, Decristoforo C (2009) Role of radiopharmaceuticals in the diagnosis and treatment of neuroendocrine tumours. Eur J Cancer 45(Suppl 1):274–291PubMedCrossRefGoogle Scholar
  46. Virgolini I, Yang Q, Li SR, Angelberger P, Neuhold N, Niederle B, Scheithauer W, Valent P (1994) Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors. Cancer Res 54:690–700PubMedGoogle Scholar
  47. Wallin Nils L (1991) Biomusicology: neurophysiological, neuropsychological, and evolutionary perspectives on the origins and purposes of music. Pendragon Press, StuyvesantGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Remigius Orjiukwu
    • 1
  • Margot Staudinger
    • 1
  • Daniel Putzer
    • 1
  • Dietmar Waitz
    • 1
  • Michael Gabriel
    • 1
  • Irene J. Virgolini
    • 1
    • 2
  1. 1.Department of Nuclear MedicineMedical University of InnsbruckInnsbruckAustria
  2. 2.Universitätsklinik für NuklearmedizinInnsbruckAustria

Personalised recommendations